AROVELLA THERAPEUTICS LIMITED - Charts / Financials

Market Cap $131.2M Add to my watchlist

Healthcare

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Combining science, nature and human compassion, Little Green Pharma (ASX:LGP) are committed to improving the quality of life for sufferers of debilitating chronic conditions. NEWS: Little Green Pharma shares surge as Germany legalises Cannabis.

REFRESH

Last update - 15.22pm 09/05/2024 (20 minute delay)

Day
Open	12.5¢		Day High	12.5¢		Day Low	12.0¢
Daily Volume	1049740

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
11	12.0¢	494725		6	12.5¢	29845

Directors & Senior Management

Mr. Michael Baker	Chief Executive Officer, Managing Director, Director
Mr. Tim Luscombe	Chief Financial Officer, Company Secretary
Dr. Nicole van Der Weerden	Chief Operating Officer
Dr. Thomas Duthy	Non-Executive Chairman of the Board
Dr. Elizabeth Stoner	Non-Executive Director
Dr. Debora Barton	Non-Executive Independent Director
Mr. Gary Jonathan Phillips	Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last 12.5¢		Change 0.000(0.00%)		Mkt cap ! $131.2M

Open	High	Low	Value	Volume
12.5¢	12.5¢	12.0¢	$130.6K	1.049M

Buyers (Bids)

No.	Vol.	Price($)
11	494725	12.0¢

Sellers (Offers)

Price($)	Vol.	No.
12.5¢	29845	6

View Market Depth

No.	Vol.	Price($)
11	494725	0.120
11	415800	0.115
11	552672	0.110
11	501529	0.105
19	732920	0.100

Price($)	Vol.	No.
0.125	29845	6
0.130	1260444	12
0.135	2316065	8
0.140	689157	12
0.145	28615	2

Last trade - 16.10pm 09/05/2024 (20 minute delay)


Last 12.5¢		Change 0.000 ( 4.17 %)
Open	High	Low	Volume
12.5¢	12.5¢	12.0¢	528422
Last updated 15.22pm 09/05/2024 ?

ALA (ASX) Chart

AROVELLA THERAPEUTICS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories